Join our next Genetics and Omics meeting... more details here 👇

Don't miss this unique opportunity as a Research Fellow in #Epigenetics! Be part of an exciting project: Validate new treatment targets for ALS/MND by evaluating methylation targets. Closing date: July 17, 2024. 🧠⚡🧬 #Epigenetics #ALS #neuroscience

Join us tomorrow for this interesting talk! More details here 👇

🚀 We've launched a new platform to bring MND ALS FTD research updates and insights to everyone, without the heavy scientific jargon. Stay connected with the latest from @united2endmnd @UKMNDRI @UKDRI @kingsmnd @mndresearch @ALSMNDAlliance @MNDOxford, @alsassociation @UCLIoN @lifearc1 and more. 🌟 Missed our 1st meeting? No worries! We meet every three months to share updates, discuss new funding, MND advocacy, and hear from both researchers and those living with ALS. 👩‍🔬 This inclusive platform welcomes PhD students, researchers, mentors, and individuals with ALS MND or at risk. Want to present your work? Get in touch! Let’s make research accessible to all. @dsetters @onein300 @AberdareNic @AmmarAlChalabi @FrattaLab @PaulPdwright27 @zyao2010 @DEMONNetworkUK

It is ALS awareness month and we are hosting a special event by our Drug Discovery group @AhmadAlKhleifat Join us on May 29 at 1 PM UK time More details here 👇👇

Happening today! Don't forget to register to attend the meeting

Join us for this interesting talk by @kurtmountain on common #genetic variants influencing #PSP risk .... for more details, check here 👇

Do not miss this interesting talk from @AtienzarSara on harnessing genetic data for drug discovery Happening today at 3 PM UK time DM for more details @AhmadAlKhleifat

Join the @DEMONNetworkUK drug discovery and trial optimisation WG for this interesting talk, for more details 👇👇

📢Join the @DEMONNetworkUK Biomarkers WG this Friday, April 26th, at 10am GMT to hear @IvanKoychev talking about the new exciting “ARUK Blood Biomarker Challenge READ OUT programme design" Join the network or contact us for more details

📢NIHR Funded PhD Opportunity - please forward and help promote this opportunity to work with us 😀 "AI-enhanced dementia prevention: precision risk reduction using large language models" exeter.ac.uk/study/funding/a…

Another interesting talk from the DEMON genetics and omics working group! Happening tomorrow at 2:30 PM (UK time)

Join our next @DEMONNetworkUK seminar on Thursday, 28th March, 2 PM GMT, with an interesting talk from Prof. Frank R.Lin on Hearing Intervention, Cognition, & Brain Health: Results from the ACHIEVE Randomized Trial To get the meeting link Register here👇 demonnetwork.com/join

Not to be missed! Join our next genetics and omics WG meeting on Thursday at 2:30 pm GMT

Join our next @DEMONNetworkUK #Genetics and #Omics meeting on THURSDAY 8th February at 2.30 PM (UK Time). Delighted to have @KristinSLevine and Emily Simmonds as invited speakers – “Sleep disturbances as risk factors for #neurodegeneration later in life”

Join Prof Winston Hide from Harvard University who will be discussing pathway targeting in Alzheimer’s disease with the @DEMONNetworkUK

🧠 Join us at @DEMONNetworkUK's Drug Discovery and Trial Optimisation working group for a special event this month. Explore "Pathway Targeting in Alzheimer's Disease: Bridging From Humans to Representative Model Systems in Therapeutic Discovery" with Dr. Winston Hide on Feb 28th at 4 pm. Don't miss this discussion! #Alzheimers Learn more about Dr. Hide and his expertise: hsci.harvard.edu/people/wins…🌐📚

Join our next genetics and omics group meeting on Thursday Details👇👇

Happening today!

Join us at @DEMONNetworkUK 's Drug Discovery and Trial Optimisation working group for a special event this month featuring Dr. Mohammad Al-Ubaydli (@idiopathic), Founder & CEO of Patients Know Best (@patientsco). 🏥📊 Mark your calendars for January 22nd at 11 am 🇬🇧 - we'll be discussing "Research with patients who know best" and its impact on health care Learn more about Dr. Al-Ubaydli and his pioneering work: patientsknowbest.com/about/ #HealthcareInnovation#ResearchTalk 📚🩺💡